Inspira's art100 in use at tier-1 u.s. hospitals, generating strong clinical interest and accelerating sales discussions

Ra'anana, israel, june 11, 2025 (globe newswire) -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) ("inspira," “inspira technologies,” or the "company"), a pioneer in innovative life-support and diagnostic technologies, announced today that its fda-cleared art100 system adoption has begun to positively impact commercialization interest and efforts, representing a key milestone and significantly contributes to the company's commercial validation.
IINN Ratings Summary
IINN Quant Ranking